You are here
Pharmos Corporation
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
PRODRUGS AND AQUEOUS FORMULATIONS OF DEXANABINOL
Amount: $100,000.00N/A
SBIRPhase I1997Department of Health and Human Services -
DEVELOPMENT OF A NONSURFACTANT FORMULATION FOR INDUCING AGENTS
Amount: $318,778.00ADVERSE REACTIONS HAVE BEEN REPORTED TO OCCUR AFTER ADMINISTRATION OF COMPOUNDS SOLUBILIZED IN AQUEOUS VEHICLES. THESE SIDE EFFECTS MAY BE REDUCED OR ELIMINATED BY COMBINING THE PRIMARY INDUCING AGENT ...
SBIRPhase II1992Department of Health and Human Services -
PARENTERAL FORMULATION FOR CARBAMAZEPINE
Amount: $500,000.00THE FAVORABLE EFFICACY, TOXICITY AND ADVERSE SIDE-EFFECT PROFILES OF CARBAMAZEPINE (CBZ) CONTRIBUTE TO ITS WIDESPREADAND INCREASING USE TO CONTROL SEIZURES IN THE EPILETPTIC PATIENTS. HOWEVER, IN CASE ...
SBIRPhase II1992Department of Health and Human Services -
PARENTERAL FORMULATION FOR CARBAMAZEPINE
Amount: $49,941.00N/A
SBIRPhase I1991Department of Health and Human Services -
IMPROVED THERAPY FOR DEPRESSION
Amount: $50,000.00DEPRESSION IS A HETEROGENOUS DISEASE, COVERING A RANGE OF SEVERITY, QUALITIES, AND CAUSES THAT AFFECTS AN IMPORTANT PORTION OF POPULATION. NONE OF THE AVAILABLE TREATMENT MODALITIES OF DEPRESSION, INC ...
SBIRPhase I1990Department of Health and Human Services -
DEVELOPMENT OF A NONSURFACTANT FORMULATION FOR INDUCING AGENTS
Amount: $45,390.00N/A
SBIRPhase I1990Department of Health and Human Services -
CROSS-AXIS COIL PLANET CENTRIFUGE CHROMATOGRAPH DESIGN AND SYNTHESIS OF BRAIN-SPECIFIC ANTIHERPETIC AGENTS
Amount: $416,005.00A NEW COUNTERCURRENT CHROMATOGRAPHY INSTRUMENT, THE CROSS-AXIS FLOW-THROUGH COIL PLANET CENTRIFUGE IS PROPOSED FOR THE PREPARATIVE CHROMATOGRAPHY OF PEPTIDES. THIS IS AN APPARATUS THAT SEPARATES SUBST ...
SBIRPhase II1989Department of Health and Human Services -
IMPROVED THERAPY FOR CNS TOXOPLASMOSIS
Amount: $50,000.00CEREBRAL TOXOPLASMOSIS IS THE MOST COMMON OPPORTUNISTIC DISEASE AFFECTING THE BRAIN OF PATIENTS WITH ACQUIRED IMMUNEDEFICIENCY SYNDROME (AIDS). SULFONAMIDE TREATMENT IS INITIALLY EFFECTIVE IN TREATING ...
SBIRPhase I1989Department of Health and Human Services -
IMPROVED DELIVERY OF ANTIVIRALS FOR CNS INFECTIONS
Amount: $50,000.00HUMAN CYTOMEGALOVIRUS (HCMV) IS A COMMON AND NOT USUALLY SERIOUS INFECTIVE AGENT. HOWEVER, IN THE CASE OF ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) AND OTHER IMMUNO-SUPPRESSEDSTATES, HCMV IS INORDINAT ...
SBIRPhase I1988Department of Health and Human Services -
ORAL DELIVERY OF A SUSTAINED ESTRADIOL DELIVERY SYSTEM
Amount: $462,000.00STUDIES ARE PROPOSED TO EVALUATE THE FEASIBILITY OF ORAL 17BETA-ESTRADIOL (E2) ADMINISTRATION USING A NOVEL REDOX SYSTEM. THIS CHEMICAL DELIVERY SYSTEM (CDS) IS BASED ON AN INTERCONVERSION OF A LIPOPH ...
SBIRPhase II1988Department of Health and Human Services
